Portfolio company
Flindr Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops small molecule inhibitors for the precision treatment of cancer patients with specific tumor and host factors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Flindr
The company develops small molecule inhibitors for precision oncology treatments to improve outcomes for cancer patients.
KyDo Therapeutics
This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.
Accent Therapeutics
This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.
Enedra Therapeutics Ltd
This company develops precision medicines and biomarkers to treat advanced, genetically heterogeneous cancers for patients with drug-resistant tumours.
Fore Bio
This biotechnology company develops precision oncology therapies and small-molecule inhibitors for patients with unaddressed tumour mutations and hard-to-treat cancers.
iOnctura
The company develops precision small-molecule medicines to treat patients with neglected and hard-to-treat solid tumours and cancers.
KyDo
This biotechnology company develops small molecule inhibitors for the treatment of cancer variants in oncology patients.
Frontier Medicines
This biopharmaceutical company develops small-molecule precision medicines targeting undruggable proteins for patients with cancer and immunological diseases.